ArticleCancer discovery2014
A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.
Brian C Grabiner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
276 papers cite itlatest 60 shown
this papertrialcites it